Technical leadership, predictive analytics, and personalized medicine can improve patient care. Here's what leaders in ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Cell and gene therapy tout promising results, but manufacturing challenges around personalized treatments require industry ...

We are on the cusp of reimagining healthcare, with AI, wearables, multimodal data, AR/VR, and other innovations rapidly accelerating the field. Over the last few years, the medical community has ...

Large language models (LLMs) like OpenAI’s ChatGPT have already demonstrated remarkable proficiency in handling textual data, ...

AI is not only improving efficiency but also driving equitable and personalized healthcare solutions worldwide. As the industry continues to evolve, AI’s role in healthcare will expand further ...

As we step into 2025, personal health remains a top priority. With advancements in healthcare and wellness technology, taking ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.